Tuesday, August 26, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

LivePersons Financial Performance for Q4 2023 A Mixed Bag

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Technology Blockchain Markets and money
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

LivePerson’s financial performance for Q4 2023 was a mixed bag, with total revenue reaching $95.5 million, slightly surpassing their forecast but down 22.1% from the previous year. The company reported a loss of $40.5 million, translating to losses per share of 48 cents, missing Wall Street’s projections. Looking ahead to Q1 2024, LivePerson’s revenue guidance fell short of expectations, with estimates between $79 million to $83 million for the quarter and full-year revenue projected at $300 million to $315 million. Following these results, LivePerson’s shares took a hit in the market.

LivePerson Inc. (LPSN) Stock Plummets 42.92% on February 29, 2024

On February 29, 2024, LivePerson Inc. (LPSN) experienced a significant drop in its stock price, trading near the bottom of its 52-week range and below its 200-day simple moving average. The stock opened at $1.71, which was $0.69 lower than its previous close, and saw a decrease of $1.03 since the market last closed, resulting in a 42.92% drop.

LPSN Stock Performance Analysis: Revenue Up, Net Income Down – February 29, 2024

On February 29, 2024, LPSN stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was reported at $514.80 million, which represented a 9.62% increase compared to the previous year. In the third quarter, LPSN generated $101.33 million in total revenue, reflecting a 3.91% increase from the previous quarter.

However, despite the growth in total revenue, LPSN’s net income showed a significant decline. The company reported a net income of -$225.75 million for the past year, marking an 80.64% decrease from the previous year. In the third quarter, LPSN recorded a net income of -$53.31 million, which represented a staggering 592.63% decrease from the previous quarter.

Furthermore, LPSN’s earnings per share (EPS) also experienced a decline. The company reported an EPS of -$3.03 for the past year, reflecting a 68.75% decrease from the previous year. In the third quarter, LPSN’s EPS was reported at -$0.68, indicating a 677.68% decrease from the previous quarter.

Overall, LPSN’s stock performances on February 29, 2024, were impacted by the significant decline in net income and EPS, despite the growth in total revenue. Investors may need to closely monitor the company’s financial performance and strategic initiatives to assess its long-term growth potential and stock value.

Tags: LPSN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances-and-tech

The Lucrative Investment Opportunity of HR Block NYSE HRB Stock

Finances

Analyzing Perspectives on CCC Intelligent Solutions Insights from Financial Experts

Finance_Financialization

Analyst Ratings and Price Targets for Advance Auto Parts A Breakdown

Recommended

Technology Data analytics stock Trading

Analyst at Wedbush Reaffirms Neutral Rating on Logitech International with 90 Price Target

2 years ago
Eli Lilly Stock

Leadership Shift at Eli Lilly Raises Investor Concerns

6 days ago

Collaboration Between Erasca Inc and Novartis to Advance Clinical Development of Combination Therapy for Solid Tumors and Melanoma

2 years ago
Finance_Capitalistic

Analyzing Analyst Ratings and Price Targets for APA Stock

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE Adobe ADSK ALB AMD AMZN AVGO BA C COIN Coinbase COST CRWD DELL DIS DWAC Eli Lilly EQT GM GRFS IBM INTC Intel JPM LLY META Micron MSFT NFLX NIO NVDA NVO PARA PLTR PLUG Robinhood SMCI Strategy TGT TSLA UNH VZ
No Result
View All Result

Highlights

Is Pepsi’s Stock Rally Built on Shaky Ground?

Tilray Shares Surge on Potential US Cannabis Policy Shift

Oracle’s High-Stakes AI Bet: Strategic Alliances Meet Operational Overhaul

A Critical Juncture for Atomera: Delayed Breakthrough Tests Investor Patience

Micron’s Market Paradox: Strong Fundamentals Meet Investor Skepticism

Alphabet Stock Defies Market Downturn with Notable Gains

Trending

Palantir Stock
Stocks

Palantir Shares Face Critical Test After Stunning Rally

by Andreas Sommer
August 26, 2025
0

The remarkable ascent of Palantir Technologies Inc. shares has hit a significant pause, with the stock showing...

Coinbase Stock

Coinbase Faces Mounting Pressure as Crypto Markets Tumble and Security Concerns Resurface

August 26, 2025
Corcept Therapeutics Stock

Corcept Therapeutics Navigates Supply Constraints Amid Strong Product Demand

August 26, 2025
Pepsi Stock

Is Pepsi’s Stock Rally Built on Shaky Ground?

August 26, 2025
Tilray Stock

Tilray Shares Surge on Potential US Cannabis Policy Shift

August 26, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Palantir Shares Face Critical Test After Stunning Rally August 26, 2025
  • Coinbase Faces Mounting Pressure as Crypto Markets Tumble and Security Concerns Resurface August 26, 2025
  • Corcept Therapeutics Navigates Supply Constraints Amid Strong Product Demand August 26, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com